Epidemiology, treatment and healthcare utilization in patients with diabetes mellitus – a population-based observational study using data from the Stockholm healthcare region

Study identification

• EU PAS number:
  EUPAS31146
• Study ID:
  31147
• Official title and acronym:
  Epidemiology, treatment and healthcare utilization in patients with diabetes mellitus – a population-based observational study using data from the Stockholm healthcare region
• DARWIN EU® study:
  No
• Study countries:
  Sweden
• Study description:
  None
• Study status:
  Ongoing

Research institutions and networks

Institutions

Forskning och Innovation

Region Stockholm

Study timelines

Date when funding contract was signed

Actual:21/11/2018

Study start date

Actual:15/03/2019

Date of final study report

Planned:31/12/2019

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Eli Lilly Sweden AB, Boehringer Ingelheim AB, Bayer AB, Novo Nordisk Scandinavia AB

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable